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Abstract 
Purpose: To present a case of primary mixed (clear cell and endometrioid type) 
adenocarcinoma of the rectovaginal septum, probably arising from endometriosis and 
associated with a highly differentiated, early-stage endometrioid endometrial carcinoma. 
The case was managed by a minimally invasive approach and postoperative adjuvant 
chemotherapy.  
Results: The patient underwent clinical/instrumental follow-up and a second-look 
laparoscopy after the primary surgery as well as adjuvant chemotherapy. No evidence of 
disease could be observed after the treatment.  
Conclusion: Surgery with postoperative chemotherapy can be recommended for the 
treatment of mixed adenocarcinoma of the rectovaginal septum. 
 
Introduction 
Although endometriosis cannot be termed a premalignant disease, epidemiologic, 
histopathologic and molecular data suggest that this condition does have malignant 
potential [1]. In the literature, 14 cases of primary adenocarcinoma of the rectovaginal  
Case Rep Oncol 2011;4:149–154 
DOI: 10.1159/000326067 
Published online: 
March 18, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
150
septum have been described. The most frequent histological type is papillary 
adenocarcinoma; adenoacanthomas or clear cell adenocarcinomas are less common [2, 3]. 
The most common treatment approach consists of surgery in combination with either 
neoadjuvant or adjuvant radiation therapy [2, 4–6]. 
We report the case of a young woman with mixed (clear cell and endometrioid type) 
adenocarcinoma of the rectovaginal septum associated with benign endometriosis, 
adenomyosis and with foci of endometrioid endometrial adenocarcinoma (G1, stage Ia).  
Case Report 
A 36-year-old nulliparous Caucasian woman complained of abdominal discomfort. A CT scan was 
performed and a 75 × 40 mm retro-uterine mass, probably of ovarian origin, was reported on the left 
paramedian side. The patient’s past medical and surgical history was uneventful and her gynaecological 
history was characterized by irregular and copious menstrual cycles. Consequently, she was referred to 
our out-patient oncology clinic with the suspicion of an ovarian mass. The patient did not complain of 
painful, perimenstrual symptoms suggestive of endometriosis. 
On clinical examination, the pelvis was almost completely occupied by a solid, painful, retrocervical 
mass, adherent to the vaginal apex and involving the rectovaginal septum. The uterus was poorly mobile 
and no palpated adnexal masses were observed. An ultrasound scan revealed that both ovaries were 
slightly enlarged and prolapsed into the Douglas pouch, with no ovarian masses. They were adherent to 
a big, solid, retrocervical mass with a mean diameter of 85 mm, internal hyperechoic areas, irregular 
external profile, no cleavage planes with surrounding tissues and with marked vascularisation at power 
Doppler imaging. The endometrial layer was thickened and irregular. The ultrasound exploration of the 
pelvic and abdominal peritoneum revealed mild ascites with no peritoneal implants or other masses. A 
chest X-ray was unremarkable, while serum levels of Ca125 and Ca19.9 were markedly elevated. After a 
comprehensive counseling, the patient was scheduled for laparoscopic biopsy of the mass, the ovaries 
and the endometrium, with subsequent frozen section (FS) examination. The patient was also fully 
informed about the surgical plans according to the FS outcomes or the laparoscopic findings. An 
informed consent was obtained, and before laparoscopy, a fractional curettage was performed. 
At diagnostic laparoscopy (fig. 1), we found an 8-cm rectovaginal mass invading the parietal 
peritoneum of the Douglas pouch, with an irregular cauliflower surface, marked superficial 
vascularisation and poor cleavage planes with the ovaries, the posterior isthmic wall and the rectum. 
The ovaries were slightly enlarged, adherent to the previously described mass, with superficial 
endometriotic implants on their surfaces. On the peritoneum of the Douglas pouch, superficial brown 
implants suggestive of peritoneal endometriosis were present. Other abdominal organs and the 
peritoneum were macroscopically normal. Mild ascitic fluid was found. A peritoneal fluid sample was 
collected and sent for cytological examination. Biopsy specimens were taken from the rectovaginal 
mass, from both ovaries and from the pelvic peritoneum. Laparoscopic biopsies were removed 
separately through the right lateral trocar using endobags. All biopsies were sent for FS analysis, which 
showed that the retro-uterine mass and the pelvic peritoneum were infiltrated by a poorly differentiated 
adenocarcinoma. The endometrial biopsy revealed endometrial hyperplasia with foci of endometrioid 
carcinoma. Both ovarian biopsy specimens were free from neoplasia. 
Based on the results from the FS examination, the patient underwent laparoscopic/minilaparotomic 
resection of the mass, radical hysterectomy, pelvic peritonectomy, pelvic and lumboaortic 
lymphadenectomy, omentectomy, rectal resection with a low pelvic colorectal anastomosis protected by 
ileostomy, and appendicectomy. There was no evidence of macroscopic disease at the end of surgery. 
There were no intraoperative complications and the postoperative course was uneventful. The patient 
was discharged on postoperative day 7. Subsequently, she underwent 1 cycle of carboplatin + paclitaxel 
chemotherapy, which, however, had to be interrupted for allergic reaction and replaced by 2 cycles of 
cisplatinum chemotherapy. A second-look procedure with closure of the ileostomy was done 2 months 
later. There was no evidence of disease.   
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Results 
Grossly, the tumour was haemorrhagic, necrotic, with irregular outlines, growing 
posterior to the uterus and the cervix. The uterus was enlarged (7.5 × 4 × 3.5 cm), as were 
both ovaries, which presented with multiple, round, dark brownish cysts. The pelvic 
peritoneum showed multiple yellow-tan solid nodules measuring up to 1.5 cm. 
Microscopically, the tumour composed of epithelial cells with severe atypia arranged in a 
glandular and solid pattern with endometrioid differentiation; a clear cell differentiation 
was also present in the lesion. The endometrial component was represented in about 80% 
(fig. 2) and the clear cell component in about 20% of the mass (fig. 3). Special staining 
revealed abundant periodic acid-Schiff cytoplasmatic positivity, with numerous 
cytoplasmatic vacuoles positive for mucin. Immunohistochemical results for CK7 and ER 
receptor showed positivity only in the endometrioid component; vimentin, however, was 
strongly positive in the endometrioid component and focally positive in clear cells. In the 
endometrium, a well-differentiated (G1) endometrioid carcinoma with a villoglandular 
pattern of the anterior uterine wall could be found. The lesion showed superficial 
infiltration (M1). On the myometrial level, diffuse adenomyosis with an intact serosal 
surface was identified. The carcinoma did not involve the ovaries, which, however, both 
showed foci of endometriosis. 
Discussion 
Primary adenocarcinoma of the rectovaginal septum is a very rare pathological entity. 
Most of the patients (70%) develop their malignancies in the setting of endometriosis. In 
1925, Sampson [7] first reported 7 cases of malignant transformation of endometriosis to 
adenocarcinoma and postulated the following criteria to define a neoplasm originating 
from endometriosis: (1) the histological type of the neoplasm must be compatible with an 
endometrial origin, (2) no other primary site should be found, and (3) endometriosis 
must be adjacent to the neoplasm. Because our case fulfilled all these criteria, we 
hypothesized that the retrouterine adenocarcinoma was a malignant transformation of 
rectovaginal septum endometriosis. In addition, our patient had a well-differentiated, 
early-stage endometrioid adenocarcinoma with myometrial infiltration of less than 50% 
in the anterior uterine wall. Hence, a theory of direct spread from the endometrial 
malignancy can be excluded. 
Because of the small number of reported cases with rectovaginal septum tumours, 
there is no consensus regarding the optimal treatment of this disease. Traditionally, the 
management involved surgery in combination with either neoadjuvant or adjuvant 
radiation therapy [2–6]. The most frequent histological types and treatments are 
summarized in table 1. 
Conclusion 
In conclusion, we want to emphasize 3 issues regarding this case: (1) the malignant 
potential of endometriosis and the existence of a mixed histological type of the 
rectovaginal adenocarcinoma (80% endometrioid and 20% clear cell carcinoma); (2) the 
concomitant presence of a highly differentiated endometrial carcinoma of the uterine  
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body and a carcinoma of the rectovaginal septum, and (3) the importance of the one-step, 
minimally invasive management of the case after comprehensive counseling and FS 
examination. 
 
 
 
Table 1. Histological types and treatments of rectovaginal septum tumours 
Case 
No. 
Reference, year  Age 
years 
Histological type  Treatment  Follow-up 
01 Hoeppner  [8],  1931  43  Unknown  RT  Unknown 
02  Vogt [9], 1937  53  Unknown    NR 10 months 
03  Dockerty et al. [10], 1954  54  Unknown  TH+BSO+LN/RT  DOD 2 years 
04  Dockerty et al. [10], 1954  45  Unknown  TH+BSO+LN/RT  NR 10 years 
05  Ferreira and Clayton [11], 1958  44  Unknown  TH+BSO  NR 3 years 
06  Lash and Rubenstone [12], 1959  35  Unknown  Cervicectomy, RR  Unknown 
07  Davis [13], 1967    Unknown  TH+RR  Died 11 months later  
of pelvic recurrence 
08  Young and Gamble [14], 1969  47  Adenoacanthoma  Pelvic exenteration+RT  Unknown 
09  Goldberg et al. [3], 1978  Unknown  Clear cell adenocarcinoma TH+LN+RR+resection of the  
upper half of the vagina 
 
10  Addison et al. [15], 1979  56  Unknown  RT/CT  DOD 1 years 
11  Yazbeck et al. [6], 2005  25  Papillary adenocarcinoma  RT/TH+RR  NR 2 years 
12  Berger et al. [4], 2001  58  Acinar and papillary  
adenocarcinoma 
TH+BSO+RR+colpectomy+RT RE  5  years  later 
13  Ulrich et al. [5], 2005  51  Glandular and papillary 
tumor 
RR+BSO+vagina and  
parakolpium resection+LN+RT 
RE 2 years later 
14  Guiou et al. [2], 2008  52  Clear cell adenocarcinoma  CT  NR 
RT = Radiation therapy; TH = total hysterectomy; BSO = bilateral salpingo-oophorectomy; LN = lymph node dissection; CT = 
chemotherapy; RR = rectal resection; RE = recurrence; NR = no recurrence; DOD = dead of disease. 
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Fig. 1. Diagnostic laparoscopic findings. (1) Rectovaginal mass. (2) Peritoneal endometriosis. 
(3) Slightly enlarged ovaries. (4) Uterus. (5) Ascites. (6) Rectum. 
 
 
 
Fig. 2. Mixed epithelial tumour: endometrioid carcinoma with a solid growth pattern (HE). 
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Fig. 3. Mixed epithelial tumour: clear cell carcinoma. The tumour cells contain glycogen which is 
stained by periodic acid-Schiff (HE). 
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